局部单次放疗增强肿瘤浸润淋巴细胞过继细胞治疗
研究在HPV阳性头颈鳞癌小鼠模型中评估放疗与过继细胞治疗(ACT)联合的疗效。肿瘤切除前5天给予单次8 Gy放疗可提高TIL扩增(96% vs 74%)和反应性,ACT当天放疗可增加T细胞浸润;联合治疗使50%小鼠达完全缓解,对照组为12.5%。
要点
- 切除前5天单次8 Gy放疗提高TIL扩增(96% vs 74%)及TNF-α产生。
- ACT当天放疗增加T细胞肿瘤浸润并改善肿瘤排斥。
- 放疗预处理后TIL行ACT使50%小鼠完全缓解,对照组12.5%。
核心结论
- 肿瘤切除前放疗增强TIL扩增、ACT当天放疗增强T细胞浸润,两时间点放疗均显著提高ACT疗效。
研究设计与样本
- 采用小鼠HPV阳性头颈鳞癌模型,肿瘤切除前5天给予单次8 Gy放疗,并行RNA测序及TIL经IL-2扩增与反应性检测。
主要发现
- 放疗预处理显著提高TIL扩增(96% vs 74%;P < .05)及TNF-α产生(P = .03)。
- 放疗显著增加TNF-α+ GzmB+ CD8+ TIL扩增(P = .02)。
- RNA测序显示趋化因子CCL21、CXCL10及其受体CCR7、CXCR4上调。
- 放疗预处理肿瘤来源TIL行ACT后50%小鼠达完全缓解,对照组为12.5%。
- ACT当天放疗较单用ACT或单用放疗增加T细胞浸润并改善肿瘤排斥。
临床怎么用
- 可考虑在肿瘤切除前给予单次放疗以改善TIL扩增,并在ACT当天放疗以增强T细胞浸润。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The potential for radiation therapy (RT) to enhance adoptive cell therapy (ACT) with tumor-reactive T cells has not been fully explored. This study evaluated combining RT with ACT, applying RT at two critical time points: (1) before tumor resection to improve ex vivo expansion of tumor-infiltrating lymphocytes (TIL) and (2) on the day of ACT using antigen-specific T cells to enhance T cell infiltration after transfer. METHODS AND MATERIALS: Using a murine human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) model, we administered single-dose RT (8 Gy × 1) 5 days before tumor resection. RNA sequencing was performed to measure chemokine expression post-RT. Tumor fragments were cultured in interleukin-2 (IL-2) for TIL expansion, and TIL reactivity was assessed through cytokine production assays. Tumor-bearing mice were treated with ACT with TIL expanded from untreated or RT-treated tumors. In additional experiments, we assessed whether RT given in combination with ACT could improve infiltration of T cells and antitumor activity. RESULTS: RT preconditioning significantly enhanced ex vivo TIL expansion (96% vs 74%; P < .05) and increased tumor necrosis factor α (TNF-α) production (P = .03), indicating improved reactivity. RT also significantly increased the expansion of TNF-α + GzmB + CD8 + TILs (P = .02), suggesting enhanced polyfunctionality within a cytotoxic subset. RNA sequencing revealed upregulation of chemokines (eg, CCL21 and CXCL10) and their receptors (CCR7 and CXCR4), supporting enhanced TIL recruitment. ACT with TIL from RT-preconditioned tumors demonstrated superior tumor control, with 50% of mice achieving complete tumor regression (CR) compared with 12.5% in controls. RT on the day of ACT increased T cell infiltration into tumor and improved tumor rejection compared with mice receiving either ACT or RT alone. CONCLUSIONS: RT at two distinct time points-before tumor resection to enhance TIL expansion and on the day of ACT to boost T cell infiltration-significantly improves the efficacy of ACT. These findings highlight the potential for combining RT with ACT to enhance therapeutic outcomes in metastatic disease.
引用
- Obertopp N, Bekker RA, Grass GD, et al. Local Single-Dose Radiation Improves Adoptive Cell Therapy With Tumor-Infiltrating Lymphocytes. Int J Radiat Oncol Biol Phys. 2025. PMID: 40582598. doi:10.1016/j.ijrobp.2025.06.3856
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。